Parallax Volatility Advisers, L.P. Amicus Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $443,992 - $601,472	50,800 Added 75.26%	118,300 $1.13 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $1.09 Million - $1.34 Million	-124,700 Reduced 64.88%	67,500 $651,000
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $394,912 - $491,344	-28,700 Reduced 12.99%	192,200 $2.89 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $816,903 - $1.06 Million	65,300 Added 41.97%	220,900 $3.18 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $1.83 Million - $2.46 Million	155,600	155,600 $2.35 Million

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.